Background Many individuals with nasopharyngeal carcinoma (NPC) face poor prognosis. with NEO212 inactivated the chemoprotective DNA fix proteins MGMT (O6-methylguanine methyltransferase), leading to significant chemosensitization of cells to another round of medications. When examined in vivo, NEO212 decreased tumor development in treated pets. Conclusion Our outcomes demonstrate anticancer activity of NEO212 in preclinical NPC versions,… Continue reading Background Many individuals with nasopharyngeal carcinoma (NPC) face poor prognosis. with